Jennifer Sanfilippo
Compliance Officer bei MELINTA THERAPEUTICS, INC.
Aktive Positionen von Jennifer Sanfilippo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MELINTA THERAPEUTICS, INC. | Compliance Officer | - | - |
General Counsel | - | - | |
Direktor/Vorstandsmitglied | 28.08.2019 | 03.08.2020 | |
Vorstandsvorsitzender | 05.08.2019 | 03.08.2020 | |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Jennifer Sanfilippo
Ehemalige bekannte Positionen von Jennifer Sanfilippo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Porzio, Bromberg & Newman PC provides legal services. Its practice area include bankruptcy, data privacy and cyber security, FDA, litigation, real estate and intellectual property. The company was founded in 1962 and is headquartered in Morristown, NJ. | Corporate Officer/Principal | - | - |
Ausbildung von Jennifer Sanfilippo
New York University | Undergraduate Degree |
Rutgers Law School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Compliance Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Porzio, Bromberg & Newman PC provides legal services. Its practice area include bankruptcy, data privacy and cyber security, FDA, litigation, real estate and intellectual property. The company was founded in 1962 and is headquartered in Morristown, NJ. | Commercial Services |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Jennifer Sanfilippo
- Erfahrung